Streetwise Articles
Analyst Says Regeneron Could Be 'Biotech Champion'
(12/17/21)
Regeneron Pharmaceuticals Inc.'s stock was up 36% in 2021 while the NASDAQ Biotechnology Index remained flat, Oppenheimer analyst Hartaj Singh reported in a Dec. 16 research note.
More >
Fabled Silver Gold Spins Out Copper Assets, 'Looks Like a Good Time to Buy'
Source: Streetwise Reports (12/16/21)
Just in time for Christmas, one junior explorer drilling off concessions in a historic silver camp in Mexico is spinning its copper assets into a red metal play in northern British Columbia; and it just announced positive new drill results at its Mexico project.
More >
Alianza Minerals, Cloudbreak Discovery Acquire and Option Out Projects
Source: The Critical Investor (12/16/21)
The Critical Investor catches up with CEO Jason Weber of Alianza Minerals about the company's latest endeavors with Cloudbreak Discovery and the status of their other projects.
More >
Co.'s Shares Gain 27% After FDA Nears Drug Approval
Source: Streetwise Reports (12/16/21)
Shares of Calliditas Therapeutics AB traded higher after the company reported the U.S. FDA granted accelerated approval for its TARPEYO™ (budesonide) to reduce proteinuria in IgA nephropathy.
More >
A Critical Q & A With Golden Independence CEO Christos Doulis
Source: The Critical Investor (12/16/21)
With the recently earned-in ownership of 51% in the Independence Gold project, the PEA coming up and potentially a much more important catalyst in Q1 2022, the Critical Investor felt it was time to conduct an interview with CEO Christos Doulis.
More >
New Team-Up Forges a Comprehensive Electronic Materials Platform
Source: Streetwise Reports (12/15/21)
CMC Materials Inc. shares traded 33% higher after the semiconductor materials company reported it agreed to be acquired by Entegris Inc. in a combination cash and stock deal valued at approximately $6.5 billion.
More >
Explorer Gaining Momentum in Push for New Discoveries at Ecuador Property
Source: Streetwise Reports (12/14/21)
Critical and precious metals explorer Aurania Resources Ltd. is methodically moving forward with is exploration program at its Lost Cities-Cutucu Project which has been shown to host significant amounts of zinc, copper, silver and other elements. Noble Capital Markets advised that the firm plans to begin exploration work at its Awacha target site in mid-December and is building momentum as it moves into 2022.
More >
Companies Partner to Reach New Depths in Nevada
Source: Streetwise Reports (12/14/21)
Nevada Exploration Inc. is looking to another local company to help shoulder the risk of gold exploration in the Silver State.
More >
Terminix to Merge With Rentokil to Create Global Pest Control Leader
Source: Streetwise Reports (12/14/21)
Terminix Global Holdings Inc. shares traded 18% higher after the company reported it has entered into a definitive agreement to be acquired by Rentokil Initial Plc. in a cash and stock transaction valued at US$6.7 billion, or about US$55/share.
More >
Target Price Raised on Biotech Based on Management Update
(12/13/21)
During its recent R&D Day, Prometheus Biosciences announced new strong trial data, another new indication for its lead therapeutic candidate and progress in developing a subcutaneous formulation of it, according to an Oppenheimer report.
More >
Resource Firm Eyes Three New Drill Targets at B.C. Gold Project
Source: Streetwise Reports (12/13/21)
Omineca Mining and Metals will focus on the placer gold component of the Wingdam project throughout 2021 then next year also take on exploring the newly identified hardrock gold targets there, a Research Capital Corporation report noted.
More >
Software Co. Reports 91% YoY Increase in Q3/21 Revenues
Source: Streetwise Reports (12/13/21)
Vancouver-based software and technology company Datable Technology Corp. is helping consumer packaged goods companies collect data from consumers who opt-in to their apps, promotions, contests, and loyalty programs. eResearch Corp. indicated that it is initiating coverage of the company with a "Speculative Buy" rating as it is now in the midst of a rapid revenue growth cycle.
More >
Osisko Sees Record Revenues With Projects Advancing
Source: Adrian Day for Streetwise Reports (12/13/21)
Adrian Day, in the Global Analyst newsletter, updates recent results and developments at several companies, large and small, with some current buys among them.
More >
Arena Pharma Takes Center Stage With Pfizer's $6.7B Cash Buyout
Source: Streetwise Reports (12/13/21)
Arena Pharmaceuticals shares traded 80% higher after the company reported it agreed to be acquired by Pfizer Inc. for $100.00 per share in cash in a deal valued at $6.7 billion.
More >
Thesis Gold Intercepts Rival That of Great Bear Resources
Source: Bob Moriarty for Streetwise Reports (12/12/21)
Bob Moriarty of 321Gold shares his thoughts on Thesis Gold Inc.'s latest promising drill results at its Ranch Gold property in British Columbia.
More >
Biopharma Explains How Its Technology Evolved, Describes Current Programs
(12/11/21)
F-star Therapeutics "has methodically delivered scientific/preclinical/early clinical data validating its platform bispecific technology," noted an Oppenheimer report.
More >
Oracle Shares Soar into the Cloud to New 52-Week High on Q2 Earnings
Source: Streetwise Reports (12/11/21)
Shares of global cloud infrastructure and enterprise software firm Oracle Corp. traded 16% higher after the company reported Q2/22 financial results that exceeded prior revenue guidance and non-GAAP earnings estimates.
More >
White Gold's Yukon Exploration Strategy Is Paying Off
Source: Streetwise Reports (12/10/21)
In part two of a two-part series, Streetwise shares more insight from White Gold CEO and Director David D'Onofrio about the company's new and exciting discoveries that include the Betty property, which intercepted 3.46 g/t Au over 50m on its maiden diamond drilling program this year, and the Ryan’s Surprise/Ulli’s Ridge district.
More >
Silver's Time to Shine: Why a 'Second-Place' Metal Will Be a First-Place Investment in 2022
Source: Streetwise Reports (12/10/21)
As Metallic Minerals wraps up its exciting programs in the Keno Hill silver district, CEO and Chairman Greg Johnson explains why the future looks bright for silver.
More >
Biopharma's Anti-PD-L1 Antibody Advances in Two Oncologic Indications
Source: Streetwise Reports (12/10/21)
Checkpoint Therapeutics' "cosibelimab represents a competitive asset on both efficacy and safety with an expected added advantage of lower net price," an H.C. Wainwright & Co. report noted.
More >
Biopharma Partners to Commercialize Enzyme Used for Kidney Transplant Patients
(12/10/21)
The partnership allows Hansa Biopharma to "enter new markets without the cost and risk of building out country-specific commercial organizations for a single product," an H.C. Wainwright & Co. report indicated.
More >
Kinross Gold to Acquire Great Bear Mining, Its Dixie Gold Project in Red Lake
Source: Streetwise Reports (12/10/21)
The market may need time to account for Kinross Gold's acquisition given Dixie's early, preresource stage despite the asset's seemingly large size potential, a Stifel GMP report noted.
More >
Coverage Initiated on Near-Term Commercial Silver Producer, Rerating Expected
Source: Streetwise Reports (12/10/21)
"Silver X marks the spot in the junior silver producer sector with the Nueva Recuperada project," noted an Echelon Capital Markets report. "We see the current valuation as a potentially rewarding risk-return proposition."
More >
Helium in Western Canada Creates Opportunities for Investors
Source: Streetwise Reports (12/9/21)
A recent Haywood Securities industry report highlights the value proposition helium offers and discusses several helium pure plays that are positioned to take advantage of strong demand growth for the gas.
More >
Explorer Continues Resource Expansion at Historic Yukon Gold District
Source: Streetwise Reports (12/9/21)
White Gold Corp. continues to deliver a steady flow of highly positive drill results and new discoveries at its 420,000 ha White Gold District property near Dawson City, Yukon. The Company has teamed up with two renowned gold producers that see vast potential in the district scale property and have made significant equity investments in the company. Analysts who cover the company believe that the firm is greatly undervalued and have issued "Buy" ratings and price targets that are far above the firm's current share price. Read part one of our two-part series.
More >